| |
Latest 10 SEC filings (by transaction date) for LQDA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 23/24 | Apr 19/24 | Saggar Rajeev | Direct Ownership | Common Stock | S - Open market or private sale | -1,649 | $13.68 |
Apr 16/24 | Apr 12/24 | Schundler Russell | Direct Ownership | Common Stock | S - Open market or private sale | -2,060 | $14.58 |
Apr 16/24 | Apr 12/24 | Saggar Rajeev | Direct Ownership | Common Stock | S - Open market or private sale | -1,525 | $14.58 |
Apr 16/24 | Apr 12/24 | Moomaw Scott | Direct Ownership | Common Stock | S - Open market or private sale | -1,585 | $14.58 |
Apr 16/24 | Apr 12/24 | Kaseta Michael | Direct Ownership | Common Stock | S - Open market or private sale | -3,136 | $14.58 |
Apr 16/24 | Apr 12/24 | Jeffs Roger | Direct Ownership | Common Stock | S - Open market or private sale | -8,360 | $14.58 |
Apr 15/24 | Apr 12/24 | Adair Jason | Direct Ownership | Common Stock | S - Open market or private sale | -1,189 | $14.58 |
Apr 15/24 | Apr 11/24 | Adair Jason | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -3,906 | |
Apr 15/24 | Apr 11/24 | Adair Jason | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 3,906 | |
Mar 19/24 | Mar 18/24 | Adair Jason | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -260 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for LQDA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 23/24 | Apr 19/24 | Saggar Rajeev | Direct Ownership | Common Stock | S - Open market or private sale | -1,649 | $13.68 |
Apr 16/24 | Apr 12/24 | Schundler Russell | Direct Ownership | Common Stock | S - Open market or private sale | -2,060 | $14.58 |
Apr 16/24 | Apr 12/24 | Saggar Rajeev | Direct Ownership | Common Stock | S - Open market or private sale | -1,525 | $14.58 |
Apr 16/24 | Apr 12/24 | Moomaw Scott | Direct Ownership | Common Stock | S - Open market or private sale | -1,585 | $14.58 |
Apr 16/24 | Apr 12/24 | Kaseta Michael | Direct Ownership | Common Stock | S - Open market or private sale | -3,136 | $14.58 |
Apr 16/24 | Apr 12/24 | Jeffs Roger | Direct Ownership | Common Stock | S - Open market or private sale | -8,360 | $14.58 |
Apr 15/24 | Apr 11/24 | Adair Jason | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -3,906 | |
Apr 15/24 | Apr 12/24 | Adair Jason | Direct Ownership | Common Stock | S - Open market or private sale | -1,189 | $14.58 |
Apr 15/24 | Apr 11/24 | Adair Jason | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 3,906 | |
Mar 19/24 | Mar 18/24 | Adair Jason | Direct Ownership | Restricted Stock Unit | M - Exercise or conversion exempt under rule 16b-3 | -260 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |